Editor Nature Biomed Eng
From Cover to Cover

An inhalable virus-like-particle vaccine against COVID-19

An inhalable virus-like-particle consisting of exosomes decorated with a recombinant SARS-Cov-2 receptor-binding domain is stable at room temperature and elicits systemic and mucosal immune responses in small animals.
Published
Go to the profile of Pep Pàmies
Pep Pàmies
Chief Editor, Nature Biomedical Engineering, Nature Research
Like
Go to the profile of Evelina Satkevic
Go to the profile of Sorrel Bunting

Read the paper

Nature
Nature Nature

Exosomes decorated with a recombinant SARS-CoV-2 receptor-binding domain as an inhalable COVID-19 vaccine - Nature Biomedical Engineering

An inhalable virus-like-particle consisting of exosomes decorated with a recombinant SARS-CoV-2 receptor-binding domain is stable at room temperature and elicits systemic and mucosal immune responses in small animals.

The cover illustrates an inhalable virus-like-particle vaccine made of exosomes derived from lung cells and decorated with a recombinant SARS-CoV-2 receptor-binding domain.

See Wang et al.

Image: Kate Zvorykina. Cover design: Alex Wing.

Go to the profile of Pep Pàmies
Pep Pàmies
Chief Editor, Nature Biomedical Engineering, Nature Research

Recommended Content